Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
about
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesGenes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigensA new method for high speed, sensitive detection of minimal residual disease.Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia: a two-year longitudinal follow-up studyDetection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.Determination of minimal residual disease in leukaemia patients.Minimal residual disease studies by flow cytometry in acute leukemia.Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.The detection and significance of minimal residual disease in acute and chronic leukemia.Characterization of acute lymphoblastic leukemia subtypes in moroccan children.Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia.Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry.Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.Infection as a cause of childhood leukemia: virus detection employing whole genome sequencing.Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.
P2860
Q24604581-19AECDC1-961A-4E3B-9411-19F94906D78FQ24685514-87DFE18D-4F98-414B-82BD-27CB55FC5E58Q24803325-C66283F4-D77A-4EA6-8D57-35FBB32DF2B5Q31030896-D7471020-73C7-449B-AC9F-DC3592112E8EQ33317811-BB816CB1-811B-4557-B379-224C7B4BCF37Q35134983-87D55C66-9253-42EA-9E3E-1A057EFB615CQ35145184-14EED8AB-2D20-48EE-BC3A-7ED05037AD59Q35792820-D5219850-04FB-4E90-B713-D9E4DBA55223Q36366977-DDF7C29A-C765-4168-87CC-AA228A5D5E8DQ36528412-2822A0F2-ED3B-4251-A966-5E09842BA33EQ36648048-9E9BEB3A-DFE5-469F-AD0D-B46CFBF775D1Q37423177-C0980119-C805-47D5-96E2-97914372983DQ38113738-460E49B7-D012-4252-A65F-E7E881B23CC7Q38377302-FC0D2C22-3C7D-407D-A8FD-70243CF59313Q40518414-05B79A7B-4455-462B-829E-A782131DDDA4Q41465370-D8DDE212-B219-48E0-9E84-4C7AB0ABAD5CQ44120226-2BC786E1-1BC1-4076-9F43-3861338C1ABAQ44670719-C90E887F-7FE3-4716-8287-DEE768FE92B0Q44721604-0E2B690D-EC8D-4B14-8009-3402DAEE80A7Q45330675-96157FDA-669C-430F-94A6-3E21CF1234B7Q54725289-A7E75630-F50E-40A9-B900-BACF277CCC00
P2860
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@ast
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@en
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@nl
type
label
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@ast
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@en
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@nl
prefLabel
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@ast
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@en
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@nl
P356
P1476
Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
@en
P2093
Dario Campana
Elaine Coustan-Smith
P356
10.1053/BEHA.2002.0182
P577
2002-03-01T00:00:00Z